Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Decision-making and challenges within the evolving treatment algorithm in spinal muscular atrophy: a clinical perspective

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d8848555e101">The clinical application of disease modifying therapies has dramatically changed the paradigm of the management of people with spinal muscular atrophy (SMA), from sole reliance on symptomatic care directed toward the downstream consequences of muscle weakness, to proactive intervention and even preventative care. </p>

          Related collections

          Most cited references124

          • Record: found
          • Abstract: found
          • Article: not found

          Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy

          Spinal muscular atrophy type 1 (SMA1) is a progressive, monogenic motor neuron disease with an onset during infancy that results in failure to achieve motor milestones and in death or the need for mechanical ventilation by 2 years of age. We studied functional replacement of the mutated gene encoding survival motor neuron 1 (SMN1) in this disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy

            New England Journal of Medicine, 377(18), 1723-1732
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy

              Nusinersen is an antisense oligonucleotide drug that modulates pre-messenger RNA splicing of the survival motor neuron 2 ( SMN2) gene. It has been developed for the treatment of spinal muscular atrophy (SMA).
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                Expert Review of Neurotherapeutics
                Expert Review of Neurotherapeutics
                Informa UK Limited
                1473-7175
                1744-8360
                July 03 2023
                June 2023
                July 03 2023
                : 23
                : 7
                : 571-586
                Affiliations
                [1 ]Department of Neurology, Sydney Children’s Hospital Network, Sydney, New South Wales, Australia
                [2 ]Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health UNSW, Sydney, Australia
                [3 ]UNSW Kensington Campus, Sydney, Australia
                Article
                10.1080/14737175.2023.2218549
                37227306
                97157603-b7cb-4e05-80bd-388072b78fd9
                © 2023
                History

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content1,188

                Cited by3

                Most referenced authors1,950